Effect of adding docetaxel to androgen-deprivation therapy in patients with high-risk prostate cancer with rising prostate-specific antigen levels after primary local therapy: a randomized clinical trial

Nom du journal : JAMA Oncol

Année : 2019

Volume : 5

Page de départ : 623

Page de fin : 632

Auteurs: Muracciole X, Sevin E, Bozec L, Miglianico L, Hardy-Bessard AC, Deplanque G, Linassier C, Priou F, Ferrero JM, Latorzeff I, Houédé N, Rolland F, Culine S, Gravis G, Oudard S, Beuzeboc P, Lagrange JL, Delva R, Caty A, Krakowski I, Ravaud A, Mouret L, Gomez P, Voog E, Abraham C, Banu E, Zylberait D, Elaidi R,